Stock data
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT) reported revenue of US$40.52M and net income of -US$160.06M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$40.52M | — | -US$160.01M | -US$160.06M | — |
| 2024 | US$32.31M | — | -US$251.15M | -US$237.09M | — |
| 2023 | US$78.12M | — | -US$169.18M | -US$153.22M | — |
| 2022 | US$19.71M | — | -US$225.95M | -US$220.43M | — |
| 2021 | US$25.54M | — | -US$193.15M | -US$192.50M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$11.89M | -US$18.23M | — |
| 2026-03-31 | US$2.83M | -US$24.98M | — |
| 2025-12-31 | US$24.74M | -US$5.62M | — |
| 2025-09-30 | US$7.54M | -US$25.12M | — |
| 2025-06-30 | US$3.58M | -US$53.23M | — |
| 2025-03-31 | US$4.66M | -US$76.09M | — |
| 2024-12-31 | US$30.61M | -US$45.40M | — |
| 2024-09-30 | US$0.06M | -US$62.14M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.